Drug intelligence / Profile preview

mangan yangyin tablets

Development stage: Unknown
Lead developer: Zhejiang Xinmingzhu Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Mangan Yangyin Tablets (慢肝养阴片) is a traditional Chinese medicine (TCM) manufactured by Zhejiang Xinmingzhu Pharmaceutical. It is specifically formulated as a tablet for the treatment of chronic hepatitis, particularly when presenting with the TCM syndrome of liver Yin deficiency. The medication is designed to nourish the liver and kidney Yin, clear heat, and resolve toxins. Clinical indications include symptoms such as hypochondriac pain, dizziness, dry mouth, and fatigue associated with chronic liver inflammation. It is an approved pharmaceutical product in China, categorized under traditional Chinese proprietary medicine.

Brand names: 慢肝养阴片Mangan Yangyin Tablets
Other names: Mangan Yangyin Pian

Beyond the preview

Go deeper on mangan yangyin tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mangan yangyin tablets.

Explore the full profile